Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial -

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
Information type: Other primary research
Source: British Medical Journal
Specialities: Obstetrics and gynaecology | Vaccination
Summary
In pregnancies conceived <90 days of bivalent HPV vaccination, there was no increased risk of miscarriage. The small increased risk of miscarriages during gestation weeks 13-20 in those conceived at any time from vaccination may be due to chance but requires further exploration.
UKMi comment
In the UK, the bivalent HPV vaccine (Cervarix®) was offered up to August 2012. The quadrivalent vaccine Gardasil® (HPV types 6, 11, 16 and 18) is now however used for the national immunisation programme.
Related links: